Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
No eligible participants were recruited
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Massachusetts General Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
The objective of this study is to identify relevant signature gene networks of cardiovascular disease in endothelial cells derived from circulating endothelial progenitor cells of individuals with established cardiovascular disease (CVD).
The investigators propose to enroll CVD and healthy subjects between 30 and 60 years of age, matched for age, gender, body mass index, and medication (statin and anti-hypertensive) use. Circulating endothelial progenitor cells will be isolated from blood and cultured in vitro to differentiate into endothelial cells.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| CVD subjects | CVD will be defined as >50% stenosis of one or more coronary arteries as assessed by coronary angiography. |
| |
| healthy controls | healthy controls defined as not having stenosis of coronary arteries as assessed by coronary angiography. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| isolation of endothelial cells precursors in blood | Other | Circulating endothelial precursor cells will be isolated and then cultured in vitro. RNA will be then isolated. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Gene expression | Gene expression [ identify relevant signature gene networks of cardiovascular disease in endothelial cells] | 10 weeks |
Not provided
Not provided
Inclusion Criteria for CVD subjects::
• >50% stenosis of one or more coronary arteries
Inclusion Criteria for Healthy subjects:
• absence of coronary artery stenosis
Exclusion Criteria for all subjects:
Not provided
Not provided
Both CVD and healthy subjects
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Stefania Lamon-Fava, PhD | Tufts University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Tufts Medical Center - Cardiovascular Clinic | Boston | Massachusetts | 02111 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| ID | Term |
|---|---|
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D001800 | Blood Specimen Collection |
| ID | Term |
|---|---|
| D013048 | Specimen Handling |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood will be obtained and subjected to isolation of circulating endothelial progenitor cells using pre-specified antibody micro-beads.
| D011677 | Punctures |
| D013514 | Surgical Procedures, Operative |
| D008919 | Investigative Techniques |